论文部分内容阅读
缺血再灌注损伤(IR I)是一种重要的病理生理现象。研究发现细胞因子在IR I发病机制中扮演重要角色。从目前的研究看,以细胞因子为治疗靶标防治IR I导致的器官损害是有前景的。
Ischemia-reperfusion injury (IRI) is an important pathophysiological phenomenon. The study found that cytokines play an important role in the pathogenesis of IRI. From the current study, the target of cytokines for the prevention and treatment of IRI organ damage is promising.